FAQ

Pseudocholinesterase Measurement

Known as: Pseudocholinesterase, Plasma Cholinesterase, Non-neuronal Cholinesterase 
The determination of the amount of total butyrylcholinesterase present in a sample.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1969-2017
05010019692017

Related topics

Related topics

8 relations
ButyrylcholinesteraseCDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameCholinesterase measurement
(More)

Related mentions per year

Related mentions per year

1944-2018
19401960198020002020
Pseudocholinesterase Measurement
Cholinesterases
Butyrylcholinesterase
Pseudocholinesterase
Cholinesterase, human
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Predictions of BuChE Inhibitors Using Support Vector Machine and Naive Bayesian Classification Techniques in Drug Discovery
Butyrylcholinesterase (BuChE, EC 3.1.1.8) is an important pharmacological target for Alzheimer's disease (AD) treatment. However… (More)
  • figure 1
  • figure 2
  • table 2
  • figure 3
  • table 3
Is this relevant?
2013
2013
Investigation of the neuroprotective action of saffron (Crocus sativus L.) in aluminum-exposed adult mice through behavioral and neurobiochemical assessment.
In the present study, the possible reversal effects of saffron against established aluminum (Al)-toxicity in adult mice, were… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2012
2012
The cholinergic system and inflammation: common pathways in delirium pathophysiology.
OBJECTIVES To investigate whether delirium is associated with an unbalanced inflammatory response or a dysfunctional interaction… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2012
2012
Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease.
Butyrylcholinesterase K (BCHE-K) is associated with increased risk of developing Alzheimer's disease (AD) in apolipoprotein… (More)
Is this relevant?
2010
2010
Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
By targeting the dual active sites of acetylcholinesterase (AChE), a new series of berberine derivatives was designed… (More)
Is this relevant?
2004
2004
The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning.
OBJECTIVE The aim of this study is to determine the effects of fresh frozen plasma, as a source of cholinesterase, on… (More)
Is this relevant?
2003
2003
Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.
Tacrine-based AChE and BuChE inhibitors were designed by investigating the topology of the active site gorge of the two enzymes… (More)
Is this relevant?
1998
1998
Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation.
The distribution of the major cholinergic regulatory enzyme acetylcholinesterase (AChE, EC 3.1.1.7) has been extensively studied… (More)
Is this relevant?
1982
1982
Pseudocholinesterase staining in the primary visual pathway of the macaque monkey
Cholinesterases in brain tissue are divided into two main classes: ‘true’ cholinesterases (acetylcholinesterase, AChE, EC 3.1.1.7… (More)
Is this relevant?
1969
1969
Electron cytochemistry of BuChE and AChE in thyroid and parathyroid C cells, under normal and experimental conditions
Thyroid and parathyroid glands of normal rats and rabbits were briefly fixed by perfusion with glutaraldehyde. Glands from… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?